Geoffrey W McCaughan, Amany Zekry  Journal of Hepatology 

Slides:



Advertisements
Similar presentations
EASL Clinical Practice Guidelines: Vascular diseases of the liver Journal of Hepatology Volume 64, Issue 1, Pages (January 2016) DOI: /j.jhep
Advertisements

Immune-mediated complications of the graft in interferon-treated hepatitis C positive liver transplant recipients  Nazia Selzner, Maha Guindi, Eberhard.
Volume 63, Issue 1, Pages (July 2015)
Volume 46, Issue 3, Pages (March 2007)
Host – hepatitis C viral interactions: The role of genetics
Therapeutic vaccines and immune-based therapies for the treatment of chronic hepatitis B: Perspectives and challenges  Marie-Louise Michel, Qiang Deng,
An integration of deep viral suppression with sequential immune modulation (cocktail therapy) to restore antiviral capacity: The future of chronic hepatitis.
Geoffrey W McCaughan, Amany Zekry  Journal of Hepatology 
Hepatic CD141+IFNλ+ DC subset: One against all?
Volume 68, Issue 5, Pages (May 2018)
Pathological roles of purinergic signaling in the liver
The yin and yang of evasion and immune activation in HCC
The inflammasome in liver disease
Reactive oxygen species in the normal and acutely injured liver
Obesity, inflammation, and liver cancer
Bridget A. Robinson, Timothy J. Nice  Immunity 
Matthew T. Kitson, Stuart K. Roberts  Journal of Hepatology 
Hepatitis C virus in the human liver transplantation model
Gianluca Tell, Carlo Vascotto, Claudio Tiribelli  Journal of Hepatology 
Volume 52, Issue 3, Pages (March 2010)
Volume 57, Issue 1, Pages 6-8 (July 2012)
NS5A inhibitors in the treatment of hepatitis C
Agustín Albillos, Margaret Lario, Melchor Álvarez-Mon 
Hepatitis C-associated B-cell non-Hodgkin lymphomas
Immigration and viral hepatitis
Immune-mediated complications of the graft in interferon-treated hepatitis C positive liver transplant recipients  Nazia Selzner, Maha Guindi, Eberhard.
Allogeneic hematopoietic cell transplant in HCV-infected patients
Liver transplantation for hepatitis B virus-related liver disease: Indications, prevention of recurrence and results  Bruno Roche, Didier Samuel  Journal.
Thomas F. Baumert, Catherine Fauvelle, Diana Y. Chen, Georg M. Lauer 
David G. Bowen, Christopher M. Walker  Journal of Hepatology 
Immunosuppressive therapy in liver transplantation
Volume 69, Issue 2, Pages (August 2018)
Natural history and predictors of severity of chronic hepatitis C virus (HCV) and human immunodeficiency virus (HIV) co-infection  Anaïs Vallet-Pichard,
Volume 59, Issue 3, Pages (September 2013)
Marina Berenguer, Detlef Schuppan  Journal of Hepatology 
Hepatitis C core protein – The “core” of immune deception?
Signalling pathways in alcohol-induced liver inflammation
Therapeutic vaccines and immune-based therapies for the treatment of chronic hepatitis B: Perspectives and challenges  Marie-Louise Michel, Qiang Deng,
I. Carmona, P. Cordero, J. Ampuero, A. Rojas, M. Romero-Gómez 
Marc van der Valk, Hans L. Zaaijer, Arnon P. Kater, Janke Schinkel 
Volume 53, Issue 4, Pages (October 2010)
Mechanisms of iron hepatotoxicity
What is the long-term outcome of the liver allograft?
A dive into the complexity of type I interferon antiviral functions
The yin and yang of evasion and immune activation in HCC
Volume 61, Issue 1, Pages S69-S78 (November 2014)
Genomic risk of hepatitis C-related hepatocellular carcinoma
Darius Moradpour, Arash Grakoui, Michael P. Manns 
Viral Hepatitis in Liver Transplantation
Autophagy in the liver Journal of Hepatology
Host-targeting agents for prevention and treatment of chronic hepatitis C – Perspectives and challenges  Mirjam B. Zeisel, Joachim Lupberger, Isabel Fofana,
HCMV jogs the ‘memory’ of NK cells in HBV
Bin Gao, Hua Wang, Fouad Lafdil, Dechun Feng  Journal of Hepatology 
Cannabinoid signaling and liver therapeutics
Senescence in chronic liver disease: Is the future in aging?
Immune-mediated complications of the graft in interferon-treated hepatitis C positive liver transplant recipients  Nazia Selzner, Maha Guindi, Eberhard.
Arjan Boltjes, Dowty Movita, André Boonstra, Andrea M. Woltman 
Volume 50, Issue 3, Pages (March 2009)
Immigration and viral hepatitis
Immunological techniques in viral hepatitis
Innate immunity and HCV
Volume 63, Issue 1, Pages (July 2015)
Macrophage heterogeneity in liver injury and fibrosis
Volume 62, Issue 3, Pages (March 2015)
Silvia Affò, Ramón Bataller  Journal of Hepatology 
Pathogenesis of cholestatic hepatitis C
Chimeric mouse model of hepatitis B virus infection
Hepatitis E virus: Infection beyond the liver?
Eric Robinet, Thomas F. Baumert  Journal of Hepatology 
Reversion of disease manifestations after HCV eradication
Presentation transcript:

Mechanisms of HCV reinfection and allograft damage after liver transplantation  Geoffrey W McCaughan, Amany Zekry  Journal of Hepatology  Volume 40, Issue 3, Pages 368-374 (March 2004) DOI: 10.1016/j.jhep.2004.01.014

Fig. 1 A proposed model for the pathogenesis of allograft injury in cholestatic hepatitis C. High levels of immunosuppression in cholestatic hepatitis result in a reduced immune response (absent CD4 responses and stable quasispecies). In addition, an intrahepatic non-specific TH2 cytokine response occurs (increased IL-10 and IL-4). Taken together, these events allow HCV to proliferate rapidly with consequent extremely high viral burdens. The absence of a specific and effective immune response in the presence of high viral burden results in HCV mediating cytopathic allograft damage. Journal of Hepatology 2004 40, 368-374DOI: (10.1016/j.jhep.2004.01.014)

Fig. 2 A proposed model for the pathogenesis of allograft injury in recurrent chronic HCV post-transplant. Increased hepatitis C viral load in the post-transplant setting appears to overcome the inhibitory effect of immunosuppression on the immune system. This results in induction of the immune system to act at a higher level than in the pre-transplant setting. As a consequence the following events occur at the molecular level: (1) an enhanced inflammatory response characterised by upregulation of IFN-γ inducible genes; (2) induction of antiviral IFN-α inducible genes which are not associated with reduced viral replication; (3) a hepatitis C virus driven enhanced proliferation, apoptosis and fibrosis response in the allograft. Acute rejection on the other hand is characterised by increased inflammation and induction of stress response related genes. Journal of Hepatology 2004 40, 368-374DOI: (10.1016/j.jhep.2004.01.014)